MELAS syndrome

3 trials MedDRA PT
3 Registered trials
0 Recruiting
2 Unique sponsors
2 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase II: 3

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

3 trials
  • Thiogenesis Therapeutics Commercial
    MERCAPTAMINE-PANTETHEINE DISULFIDE ACETATE
    2023-506723-28-00 2 countries 2025 n=12
    Ended
  • Tisento Therapeutics Inc. Commercial
    ZAGOCIGUAT
    2024-515389-15-00 2 countries 2024 n=20
    Ended
  • Tisento Therapeutics Inc. Commercial
    ZAGOCIGUAT
    2024-517514-15-00 2 countries n=14
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Tisento Therapeutics Inc. Commercial 2 Phase II 0
Thiogenesis Therapeutics Commercial 1 Phase II 0
New trials by year
2024
1
2025
1
← All indication landscapes